IL-17-deficient mice demonstrate a markedly attenuated form of collagen-induced arthritis (CIA) [2], neutralization of IL-17 during induction of experimental arthritis suppresses the onset of disease [3], and anti-IL-17 therapy in established CIA is associated with a significant reduction of severity [4]. Here, IL17A is linked to arthritic joint disease.